The practice of employing former industry executives in regulatory agencies, like Wall Streeters at the SEC or pharmaceutical execs at the FDA, raises concerns about potential conflicts […]
The practice of employing former industry executives in regulatory agencies, like Wall Streeters at the SEC or pharmaceutical execs at the FDA, raises concerns about potential conflicts […]